BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37712389)

  • 21. CASP8AP2 is a novel partner gene of MLL rearrangement with t(6;11)(q15;q23) in acute myeloid leukemia.
    Park TS; Lee SG; Song J; Lee KA; Kim J; Choi JR; Lee ST; Marschalek R; Meyer C
    Cancer Genet Cytogenet; 2009 Nov; 195(1):94-5. PubMed ID: 19837277
    [No Abstract]   [Full Text] [Related]  

  • 22. Increased risk of adverse acute myeloid leukemia after anti-CD19-targeted immunotherapies in
    Fournier E; Inchiappa L; Delattre C; Pignon JM; Danicourt F; Bemba M; Roche-Lestienne C; Daudignon A; Decool G; Roumier C; Dumezy F; Fournier L; Grardel N; Preudhomme C; Duployez N
    Leuk Lymphoma; 2019 Jul; 60(7):1827-1830. PubMed ID: 30616415
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute myeloid leukaemia (AML) with KMT2A rearrangement presented with haemophagocytic lymphohistiocytosis (HLH).
    Xu K; Nacheva E
    Int J Lab Hematol; 2024 Apr; 46(2):214-215. PubMed ID: 37807295
    [No Abstract]   [Full Text] [Related]  

  • 24. FISH improves risk stratification in acute leukemia by identifying KMT2A abnormal copy number and rearrangements.
    Li Q; Xing S; Zhang H; Mao X; Xiao M; Wang Y
    Sci Rep; 2022 Jun; 12(1):9585. PubMed ID: 35688861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gemtuzumab ozogamicin in (KMT2A)-rearranged adult acute myeloid leukaemia (AML) in the UK Medical Research Council AML15 and AML16 trials.
    Dillon R; Hills RK; Burnett AK; Russell NH
    Br J Haematol; 2022 Mar; 196(5):e50-e52. PubMed ID: 34799856
    [No Abstract]   [Full Text] [Related]  

  • 26. EPHX1 rs1051740 T>C (Tyr113His) is strongly associated with acute myeloid leukemia and KMT2A rearrangements in early age.
    Brisson GD; de Almeida Lopes B; Andrade FG; Dos Santos Bueno FV; Sardou-Cezar I; de Aguiar Gonçalves BA; Terra-Granado E; Paraguassú-Braga FH; Pombo-de-Oliveira MS
    Arch Toxicol; 2018 Jun; 92(6):2001-2012. PubMed ID: 29605894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene.
    Szotkowski T; Jarošová M; Zimmermannová O; Meyer C; Marschalek R; Zuna J; Hubáček J; Indrák K
    Cancer Genet; 2015 Dec; 208(12):610-4. PubMed ID: 26556690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
    Meggendorfer M; Haferlach T; Alpermann T; Jeromin S; Haferlach C; Kern W; Schnittger S
    Haematologica; 2014 Dec; 99(12):e244-6. PubMed ID: 25239264
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessing acute myeloid leukemia susceptibility in rearrangement-driven patients by DNA breakage at topoisomerase II and CCCTC-binding factor/cohesin binding sites.
    Atkin ND; Raimer HM; Wang Z; Zang C; Wang YH
    Genes Chromosomes Cancer; 2021 Dec; 60(12):808-821. PubMed ID: 34405474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new variant of KMT2A(MLL)-FLNA fusion transcript in acute myeloid leukemia with ins(X;11)(q28;q23q23).
    Matveeva E; Kazakova A; Olshanskaya Y; Tsaur G; Shelikhova L; Meyer C; Marschalek R; Novichkova G; Maschan M; Maschan A
    Cancer Genet; 2015 Apr; 208(4):148-51. PubMed ID: 25892123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal residual disease monitoring and preemptive immunotherapies for frequent 11q23 rearranged acute leukemia after allogeneic hematopoietic stem cell transplantation.
    Liu J; Zhang XH; Xu LP; Wang Y; Yan CH; Chen H; Chen YH; Han W; Wang FR; Wang JZ; Cheng YF; Qin YZ; Liu KY; Huang XJ; Zhao XS; Mo XD
    Ann Hematol; 2021 May; 100(5):1267-1281. PubMed ID: 33712867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The stem cell-specific long noncoding RNA HOXA10-AS in the pathogenesis of KMT2A-rearranged leukemia.
    Al-Kershi S; Bhayadia R; Ng M; Verboon L; Emmrich S; Gack L; Schwarzer A; Strowig T; Heckl D; Klusmann JH
    Blood Adv; 2019 Dec; 3(24):4252-4263. PubMed ID: 31867596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bruton's tyrosine kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.
    Nimmagadda SC; Frey S; Edelmann B; Hellmich C; Zaitseva L; König GM; Kostenis E; Bowles KM; Fischer T
    Leukemia; 2018 Mar; 32(3):846-849. PubMed ID: 29109446
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular characterization of KMT2A fusion partner genes in 13 cases of pediatric leukemia with complex or cryptic karyotypes.
    Ney Garcia DR; de Souza MT; de Figueiredo AF; Othman MAK; Rittscher K; Abdelhay E; Capela de Matos RR; Meyer C; Marschalek R; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Hematol Oncol; 2017 Dec; 35(4):760-768. PubMed ID: 27282883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of enhancer of mRNA decapping 4 as a novel fusion partner of
    Becker H; Greve G; Kataoka K; Mallm JP; Duque-Afonso J; Ma T; Niemöller C; Pantic M; Duyster J; Cleary ML; Schüler J; Rippe K; Ogawa S; Lübbert M
    Blood Adv; 2019 Mar; 3(5):761-765. PubMed ID: 30833276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel regimen for relapsed/refractory adult acute myeloid leukemia using a
    Mims AS; Mishra A; Orwick S; Blachly J; Klisovic RB; Garzon R; Walker AR; Devine SM; Walsh KJ; Vasu S; Whitman S; Marcucci G; Jones D; Heerema NA; Lozanski G; Caligiuri MA; Bloomfield CD; Byrd JC; Piekarz R; Grever MR; Blum W
    Haematologica; 2018 Jun; 103(6):982-987. PubMed ID: 29567781
    [No Abstract]   [Full Text] [Related]  

  • 37. De novo acute myeloid leukemia associated with t(11;17)(q23;q25) and MLL-SEPT9 rearrangement in an elderly patient: a case study and review of the literature.
    Lee SG; Park TS; Oh SH; Park JC; Yang YJ; Marschalek R; Meyer C; Cho EH; Shin SY
    Acta Haematol; 2011; 126(4):195-8. PubMed ID: 21846973
    [No Abstract]   [Full Text] [Related]  

  • 38. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New Complex Karyotype Involving a KMT2A-r Variant Three-Way Translocation in a Rare Clinical Presentation of a Pediatric Patient with Acute Myeloid Leukemia.
    Capela de Matos RR; Ney Garcia DR; Othman MAK; Moura Ferreira G; Melo JB; Carreira IM; Meyer C; Marschalek R; Costa ES; Land MGP; Liehr T; Ribeiro RC; Silva MLM
    Cytogenet Genome Res; 2019; 157(4):213-219. PubMed ID: 30974445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole transcriptome sequencing reveals a KMT2A-USP2 fusion in infant acute myeloid leukemia.
    Ikeda J; Shiba N; Tsujimoto SI; Yoshida M; Nakabayashi K; Ogata-Kawata H; Okamura K; Takeuchi M; Osumi T; Tomizawa D; Hata K; Kiyokawa N; Ito S; Kato M
    Genes Chromosomes Cancer; 2019 Sep; 58(9):669-672. PubMed ID: 30869817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.